BioAtla, Inc. (BCAB) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 33.4M |
| Enterprise Value | 32.48M |
| P/E Ratio | -0.07 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0.34 |
| Price/Book Ratio | -0.08 |
| Enterprise/Revenue | 0.85 |
| Enterprise/EBITDA | -0.23 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -3.7 |
| Operating Margin | -3.78 |
AD
Management Effectiveness
| Return On Assets | -3.31 |
| Return On Equity | 0.89 |
Income Statement
| Revenue | 2M |
| Revenue/Share | 5.12 |
| Gross Profit | -41.07M |
| EBITDA | -59.23M |
| Net Income | -59.61M |
| Diluted EPS | -50.5 |
Balance Sheet
| Total Cash | 1.54M |
| Total Cash/Share | 0.93 |
| Total Debt | 5.86M |
| Total Debt/Equity | -0.16 |
| Current Ratio | 0.2 |
| Book Value Per Share | -21.82 |
Price History
| 52-Week Change | -94.98 |
| 52-Week High | 71.5 |
| 52-Week Low | 1.07 |
| Moving Average 50 Days | 3.3 |
| Moving Average 200 Days | 11.87 |
Statistics
| Average Volume | 77,674 |
| Shares Outstanding | 1.66M |
| % Held by Institutions | 6.51 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:50 |
| Last Split Date | April 06, 2026 |
AD
